SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $613,546,175 |
| Positions | 24 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ALAMAR BIOSCIENCES INC | ALMR | COMMON STOCK | $114,615,785 | 4,230,926 |
| NU HLDGS LTD | NU | ORD SHS CL A | $94,788,559 | 7,094,952 |
| KLAVIYO INC | KVYO | COM SER A | $59,315,005 | 3,928,146 |
| BETA BIONICS INC | BBNX | COM | $58,105,034 | 3,708,043 |
| SPYGLASS PHARMA INC | SGP | COM SHS | $55,650,267 | 2,500,012 |
| INHIBIKASE THERAPEUTICS INC | IKT | COM NEW | $26,428,499 | 13,018,965 |
| DOORDASH INC | DASH | CL A | $23,539,016 | 127,562 |
| COUPANG INC | CPNG | CL A | $23,090,184 | 1,329,314 |
| DATADOG INC | DDOG | CL A COM | $21,050,366 | 80,851 |
| BIOAGE LABS INC | BIOA | COM | $19,273,512 | 786,353 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.